HON vs TERN · P/E 36, rev $9.72B vs $6.12B cap
Honeywell International Inc (HON) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
HON currently screens at market cap $144.86B and trailing P/E 36.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the HON and TERN stock pages for the full models.
Not investment advice.